Literature DB >> 16898855

Diuretics in pediatrics : current knowledge and future prospects.

Maria M J van der Vorst1, Joana E Kist, Albert J van der Heijden, Jacobus Burggraaf.   

Abstract

This review summarizes current knowledge on the pharmacology, pharmacokinetics, pharmacodynamics, and clinical application of the most commonly used diuretics in children. Diuretics are frequently prescribed drugs in children. Their main indication is to reduce fluid overload in acute and chronic disease states such as congestive heart failure and renal failure. As with most drugs used in children, optimal dosing schedules are largely unknown and empirical. This is undesirable as it can potentially result in either under- or over-treatment with the possibility of unwanted effects. The pharmacokinetics of diuretics vary in the different pediatric age groups as well as in different disease states. To exert their action, all diuretics, except spironolactone, have to reach the tubular lumen by glomerular filtration and/or proximal tubular secretion. Therefore, renal maturation and function influence drug delivery and consequently pharmacodynamics. Currently advised doses for diuretics are largely based on adult pharmacokinetic and pharmacodynamic studies. Therefore, additional pharmacokinetic and pharmacodynamic studies for the different pediatric age groups are necessary to develop dosing regimens based on pharmacokinetic and pharmacodynamic models for all routes of administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16898855     DOI: 10.2165/00148581-200608040-00004

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  210 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  The effect of aerosolized furosemide in infants with chronic lung disease.

Authors:  Y Ohki; Y Nako; T Koizumi; A Morikawa
Journal:  Acta Paediatr       Date:  1997-06       Impact factor: 2.299

3.  Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.

Authors:  J E Sullivan; M K Witte; T S Yamashita; C M Myers; J L Blumer
Journal:  Clin Pharmacol Ther       Date:  1996-10       Impact factor: 6.875

4.  Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts.

Authors:  S Shinnar; K Gammon; E W Bergman; M Epstein; J M Freeman
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

5.  Hematologic reactions to carbonic anhydrase inhibitors.

Authors:  F T Fraunfelder; S M Meyer; G C Bagby; M W Dreis
Journal:  Am J Ophthalmol       Date:  1985-07-15       Impact factor: 5.258

6.  Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.

Authors:  Z Cheng; A Radominska-Pandya; T R Tephly
Journal:  Drug Metab Dispos       Date:  1999-10       Impact factor: 3.922

7.  Long-term bumetanide treatment of patients with edema due to renal disease. Cooperative studies.

Authors:  W J Stone; W M Bennett; R E Cutler
Journal:  J Clin Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.126

8.  Ovarian cyst in a premature infant treated with spironolactone.

Authors:  A J Vachharajani; J K Shah; B A Paes
Journal:  Am J Perinatol       Date:  2001-09       Impact factor: 1.862

9.  Furosemide kinetics in renal failure.

Authors:  W J Tilstone; A Fine
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

10.  Preterm neonates with nephrocalcinosis: natural course and renal function.

Authors:  Eveline A Schell-Feith; Joana E Kist-van Holthe; Paul H T van Zwieten; Harmine M Zonderland; Herma C Holscher; Dorine W Swinkels; Ronald Brand; Howard M Berger; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

View more
  10 in total

1.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

2.  Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients.

Authors:  Maysa Suyagh; Ahmed F Hawwa; Paul S Collier; Jeffrey S Millership; Prashant Kole; Muriel Millar; Mike D Shields; Henry L Halliday; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 3.  Acute kidney injury and fluid overload in infants and children after cardiac surgery.

Authors:  David M Kwiatkowski; Catherine D Krawczeski
Journal:  Pediatr Nephrol       Date:  2017-03-30       Impact factor: 3.714

4.  Renal aspects of metabolic acid-base disorders in neonates.

Authors:  Silvia Iacobelli; Jean-Pierre Guignard
Journal:  Pediatr Nephrol       Date:  2018-11-19       Impact factor: 3.714

Review 5.  Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management.

Authors:  Giacomo D Simonetti; Laura Santoro; Alessandra Ferrarini; Laura Crosazzo-Franscini; Emilio Fossali; Mario G Bianchetti
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: a randomized controlled trial.

Authors:  Zaccaria Ricci; Roberta Haiberger; Chiara Pezzella; Cristiana Garisto; Isabella Favia; Paola Cogo
Journal:  Crit Care       Date:  2015-01-07       Impact factor: 9.097

Review 7.  Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis.

Authors:  Catherine D Krawczeski
Journal:  Front Pediatr       Date:  2019-11-26       Impact factor: 3.418

8.  Association Between Furosemide Exposure and Clinical Outcomes in a Retrospective Cohort of Critically Ill Children.

Authors:  Xiaomei Dai; Jiao Chen; Wenjing Li; Zhenjiang Bai; Xiaozhong Li; Jian Wang; Yanhong Li
Journal:  Front Pediatr       Date:  2021-01-25       Impact factor: 3.418

9.  The Use of Diuretic in Mechanically Ventilated Children with Viral Bronchiolitis: a Cohort Study.

Authors:  Nisha Agasthya; Kimberlee Chromey; James H Hertzog; Jigar C Chauhan
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-05-12

10.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.